19-40458478-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_000713.3(BLVRB):c.147C>T(p.His49His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000733 in 1,608,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000069 ( 0 hom. )
Consequence
BLVRB
NM_000713.3 synonymous
NM_000713.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.566
Genes affected
BLVRB (HGNC:1063): (biliverdin reductase B) Enables biliverdin reductase (NAD(P)+) activity and riboflavin reductase (NADPH) activity. Involved in heme catabolic process. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 19-40458478-G-A is Benign according to our data. Variant chr19-40458478-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 710783.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.566 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BLVRB | NM_000713.3 | c.147C>T | p.His49His | synonymous_variant | 2/5 | ENST00000263368.9 | NP_000704.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BLVRB | ENST00000263368.9 | c.147C>T | p.His49His | synonymous_variant | 2/5 | 1 | NM_000713.3 | ENSP00000263368.3 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152176Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
18
AN:
152176
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000592 AC: 14AN: 236580Hom.: 0 AF XY: 0.0000621 AC XY: 8AN XY: 128898
GnomAD3 exomes
AF:
AC:
14
AN:
236580
Hom.:
AF XY:
AC XY:
8
AN XY:
128898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000686 AC: 100AN: 1456822Hom.: 0 Cov.: 35 AF XY: 0.0000746 AC XY: 54AN XY: 724322
GnomAD4 exome
AF:
AC:
100
AN:
1456822
Hom.:
Cov.:
35
AF XY:
AC XY:
54
AN XY:
724322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152176Hom.: 0 Cov.: 30 AF XY: 0.000108 AC XY: 8AN XY: 74334
GnomAD4 genome
AF:
AC:
18
AN:
152176
Hom.:
Cov.:
30
AF XY:
AC XY:
8
AN XY:
74334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at